We look at 5 robotic surgery stocks that have a market cap greater than $100 million. Accuracy deals in radiation so isn't robotic surgery in the strictest sense of the term. Stereotaxis isn't enjoying revenue growth, so they're not worth pursuing until that happens. Globus Medical is hardly a pure play, while Procept BioRobotics doesn't seem to have as large an opportunity as they think. That brings us to Intuitive Surgical ISRG which is a leader in surgical robotics and certainly worth a closer look at the right valuation that is.

RESEARCH PIECES USED IN THIS VIDEO:
1. Is There Growth Left for Surgical Robots?
https://www.nanalyze.com/2023/10/grow...
2. What’s the Best Robot Stock to Invest In?
https://www.nanalyze.com/2022/07/best...
3. Intuitive Surgical Stock Leads RobotAssisted Surgery
https://www.nanalyze.com/2022/02/intu...

CHAPTERS:
Intro
5 robotic surgery stocks
Stereotaxis and endovascular surgery
Accuray's radiation therapy
Globus Medical and Enabling Technologies
Procept BioRobotics and prostates
Intuitive Surgical is the leader
Conclusion

ABOUT US:
This video is brought to you by Nanalyze, a media and research firm founded by finance professionals with decades of experience. We share insights about #DisruptiveTechnology #stocks in a language that is futureproof and easy to understand.

Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30day trial of our monthly subscription with no strings attached: https://www.nanalyze.com/subscription...

DISCLAIMER: Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, along with independently researching and verifying, any information contained within our YouTube videos or on our website, whether for the purpose of making an investment or otherwise.

#robotics
#robots
$ISRG
$ARAY
$GMED
$PRCT
$STXS